OrbiMed’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.7M | Hold |
|
|||||
|
2025
Q1 | $31.8M | Hold |
|
|||||
|
2024
Q4 | $37.2M | Buy |
|
|||||
|
2024
Q3 | $35.9M | Buy |
|
|||||
|
2024
Q2 | $33.6M | Buy |
|
|||||
|
2024
Q1 | $23.7M | Hold |
|
|||||
|
2023
Q4 | $25.3M | Sell |
|
|||||
|
2023
Q3 | $32.8M | Sell |
|
|||||
|
2023
Q2 | $42.2M | Sell |
|
|||||
|
2023
Q1 | $41.1M | Hold |
|
|||||
|
2022
Q4 | $45.3M | Buy |
|
|||||
|
2022
Q3 | $41.1K | Sell |
|
|||||
|
2022
Q2 | $40.4K | Buy |
|
|||||
|
2022
Q1 | $21M | Buy |
|
|||||
|
2021
Q4 | $19.7M | Buy |
|
|||||
|
2021
Q3 | $7.29M | Sell |
|
|||||
|
2021
Q2 | $24.8M | Sell |
|
|||||
|
2021
Q1 | $44.7M | Hold |
|
|||||
|
2020
Q4 | $38.4M | Hold |
|
|||||
|
2020
Q3 | $27.7M | Hold |
|
|||||
|
2020
Q2 | $31.3M | Buy |
|
|||||
|
2020
Q1 | $18.9M | Buy |
|
|||||
|
2019
Q4 | $8.32M | Hold |
|
|||||
|
2019
Q3 | $5.72M | Hold |
|
|||||
|
2019
Q2 | $6.26M | Hold |
|
|||||
|
2019
Q1 | $6.45M | Hold |
|
|||||
|
2018
Q4 | $4.01M | Hold |
|
|||||
|
2018
Q3 | $8.38M | Hold |
|
|||||
|
2018
Q2 | $5.84M | Hold |
|
|||||
|
2018
Q1 | $3.11M | Hold |
|
|||||
|
2017
Q4 | $1.79M | Hold |
|
|||||
|
2017
Q3 | $1.87M | Hold |
|
|||||
|
2017
Q2 | $2M | Hold |
|
|||||
|
2017
Q1 | $2.54M | Sell |
|
|||||
|
2016
Q4 | $7.7M | Hold |
|
|||||
|
2016
Q3 | $8.1M | Buy |
|